RIL
LAB icon

Rothschild Investment LLC’s Standard BioTools LAB Stock Holding History

Rothschild Investment LLC’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$770 Buy
936
+368
+65% +$348 ﹤0.01% 3151
2026
Q1 		$522 Buy
568
+546
+2,482% +$661 ﹤0.01% 3113
2025
Q4 		$28 Buy
22
+21
+2,100% +$28 ﹤0.01% 3315
2025
Q3 		$1 Hold
1
– – ﹤0.01% 3134
2025
Q2 		$1 Sell
1
-120
-99% -$133 ﹤0.01% 3015
2025
Q1 		$131 Sell
121
-315
-72% -$442 ﹤0.01% 2923
2024
Q4 		$763 Buy
436
+40
+10% +$75 ﹤0.01% 2373
2024
Q3 		$764 Buy
396
+320
+421% +$627 ﹤0.01% 2336
2024
Q2 		$135 Buy
76
+75
+7,500% +$183 ﹤0.01% 2613
2024
Q1 		$3 Hold
1
– – ﹤0.01% 2266
2023
Q4 		$2 Buy
+1
New +$2 ﹤0.01% 1355

Other funds holding LAB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
OC
Oppenheimer & Co New York $9.37B AUM 36.4% 1-Year Est. Return
MAM
Marquette Asset Management Minneapolis, Minnesota $779M AUM 23.4% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Rothschild Investment LLC's LAB Position: Q2 2026 in Review

Rothschild Investment LLC increased its Standard BioTools (LAB) stake by 65% in Q2 2026, buying an estimated $348 and bringing the position to 936 shares worth $770. The position accounts for ﹤0.01% of the portfolio, ranked #3151.

Rothschild Investment LLC first reported a position in LAB in Q4 2023 and has held it in 11 quarters since. 40 funds tracked by Wall St. Rank hold LAB as of Q2 2026.

  • Rothschild Investment LLC held 936 shares of Standard BioTools worth $770 as of Q2 2026.
  • Rothschild Investment LLC bought 368 Standard BioTools shares in Q2 2026, an estimated $348.
  • Standard BioTools made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #3151 holding.
  • Rothschild Investment LLC first reported a position in Standard BioTools in Q4 2023 and has held it in 11 quarters since.
  • 40 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.